益方生物-U
(688382)
| 流通市值：129.93亿 | | | 总市值：179.92亿 |
| 流通股本：4.18亿 | | | 总股本：5.78亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,430,469,658.87 | 1,530,820,982.57 | 1,585,843,034.83 | 1,522,903,822.76 |
| 交易性金融资产 | 152,384,160 | 101,830,000 | 101,300,000 | 100,830,000 |
| 应收票据及应收账款 | 158,824,205.48 | 173,587,883.14 | 165,341,591.44 | 187,195,893.83 |
| 应收账款 | 158,824,205.48 | 173,587,883.14 | 165,341,591.44 | 187,195,893.83 |
| 预付款项 | 12,248,797.21 | 12,227,671.22 | 11,692,338.6 | 15,042,937.94 |
| 其他应收款合计 | 5,969,432.5 | 4,833,567.97 | 5,933,684.59 | 5,638,117.33 |
| 流动资产合计 | 1,759,896,254.06 | 1,823,300,104.9 | 1,870,110,649.46 | 1,831,610,771.86 |
| 非流动资产: | | | | |
| 固定资产 | 10,958,427.01 | 11,943,699.72 | 13,199,082.4 | 14,342,758.3 |
| 在建工程 | - | 9,140,707.83 | 6,470,227.44 | 2,053,141.77 |
| 使用权资产 | 23,355,236.65 | 21,526,205.19 | 25,146,651.76 | 23,930,792.31 |
| 无形资产 | 1,408,631.85 | 509,750.18 | 591,892.37 | 674,034.53 |
| 长期待摊费用 | 11,099,594.8 | - | - | - |
| 递延所得税资产 | 3,454,008.87 | 3,165,720.72 | 3,439,452.03 | 5,824,212.79 |
| 其他非流动资产 | 2,796,014.32 | 3,710,963.94 | 1,859,218.79 | 12,971,579.06 |
| 非流动资产合计 | 53,071,913.5 | 49,997,047.58 | 50,706,524.79 | 59,796,518.76 |
| 资产平衡项目 | 0 | -0.01 | 0 | 0 |
| 资产总计 | 1,812,968,167.56 | 1,873,297,152.47 | 1,920,817,174.25 | 1,891,407,290.62 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 52,504,729.25 | 54,574,331.75 | 59,963,520 | 55,572,961.54 |
| 应付账款 | 52,504,729.25 | 54,574,331.75 | 59,963,520 | 55,572,961.54 |
| 合同负债 | - | - | - | 47,169,811.32 |
| 应付职工薪酬 | 13,781,152.54 | 19,744,474.28 | 20,310,462.16 | 17,703,342.06 |
| 应交税费 | 105,148.78 | 220,568.7 | 93,790.88 | 136,788.93 |
| 其他应付款合计 | 1,296,550.45 | 1,310,625.33 | 1,625,628 | 4,616,993.31 |
| 一年内到期的非流动负债 | 7,503,578.07 | 4,157,935.28 | 7,787,941.85 | 7,572,073.63 |
| 其他流动负债 | 764,103.6 | 690,439.91 | 199,101.77 | 256,985.08 |
| 流动负债合计 | 75,955,262.69 | 80,698,375.25 | 89,980,444.66 | 133,028,955.87 |
| 非流动负债: | | | | |
| 租赁负债 | 14,976,720.53 | 18,710,644.15 | 16,134,064.48 | 16,697,283.88 |
| 递延收益 | 480,000 | 480,000 | 480,000 | 880,000 |
| 递延所得税负债 | 3,454,008.87 | 3,165,720.72 | 3,439,452.03 | 5,824,212.79 |
| 非流动负债合计 | 18,910,729.4 | 22,356,364.87 | 20,053,516.51 | 23,401,496.67 |
| 负债平衡项目 | 0 | -0.01 | 0 | 0 |
| 负债合计 | 94,865,992.09 | 103,054,740.11 | 110,033,961.17 | 156,430,452.54 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 578,327,844 | 578,327,844 | 576,745,195 | 576,745,195 |
| 资本公积 | 3,816,495,749.46 | 3,806,741,105.97 | 3,790,862,990.84 | 3,780,629,990.71 |
| 其他综合收益 | -12,363,258.57 | -12,401,787.88 | -11,899,293.19 | -12,370,003.2 |
| 未分配利润 | -2,664,358,159.42 | -2,602,424,749.73 | -2,544,925,679.57 | -2,610,028,344.43 |
| 归属于母公司股东权益合计 | 1,718,102,175.47 | 1,770,242,412.36 | 1,810,783,213.08 | 1,734,976,838.08 |
| 股东权益合计 | 1,718,102,175.47 | 1,770,242,412.36 | 1,810,783,213.08 | 1,734,976,838.08 |
| 负债和股东权益合计 | 1,812,968,167.56 | 1,873,297,152.47 | 1,920,817,174.25 | 1,891,407,290.62 |
| 公告日期 | 2025-08-23 | 2025-04-29 | 2025-04-26 | 2024-10-30 |
| 审计意见(境内) | | | 标准无保留意见 | |